Perrigo and Catalent Announce FDA Approval of Perrigo's AB-rated Generic Version of ProAirĀ® HFA

Go back to Perrigo and Catalent Announce FDA Approval of Perrigo's AB-rated Generic Version of ProAirĀ® HFA
Perrigo (NYSE: PRGO) Delayed: 9.49 --0 (-0%)
Previous Close $9.49    52 Week High $156.03 
Open $9.49    52 Week Low $79.72 
Day High $9.49    P/E N/A 
Day Low $9.49    EPS $0.00 
Volume 1,211       

Perrigo (NYSE: PRGO) Delayed: 9.49 --0 (-0%)
Previous Close $9.49    52 Week High $156.03 
Open $9.49    52 Week Low $79.72 
Day High $9.49    P/E N/A 
Day Low $9.49    EPS $0.00 
Volume 1,211